Find the latest information on COVID-19, monkeypox, and the flu vaccine
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Photopheresis is one method of apheresis therapy offered at the Stanford Cancer Center.
The treatment is also called extracorporeal ("out of the body") photochemotherapy (ECP) because it involves a light-activated drug, such as psoralen, that enters the patient's bloodstream. The patient's blood is then circulated out of the body where it is exposed to light, activating the drug before it reenters the body.
Photopheresis is most commonly used to treat cutaneous T-cell lymphomas (CTCL), such as mycosis fungoides and Sezary syndrome.
The Stanford Multispecialty Cutaneous Lymphoma Clinic (CLC) is a leading center of excellence for managing patients with CTCL. As such, it has access to multiple photopheresis units and extensive experience with this procedure.
INTERESTED IN AN ONLINE SECOND OPINION?
The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!
Visit our online second opinion page to learn more.
Stanford Cancer Center Palo AltoStanford Cancer Center provides a warm, supportive environment that enables patients and families to stay in one location for procedures and tests and focus on healing.
Stanford Medicine Cancer Center Palo Alto875 Blake Wilbur Drive
Palo Alto, CA 94304